# Iceland Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Iceland HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Iceland (ISL) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $319.6M - Products: 32 - Buyer markets: 30 - Average CAGR: +57.9% - Global sector size: $719.7B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $313.2B | $26.4M | $117.6B | +13.6% | 23 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $147.2B | $269.3M | $58.0B | +256.4% | 11 | +0.2% | | HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $29.9B | $8.3M | $48.0B | +24.8% | 4 | +0.1% | | HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $35.3B | $6.1M | $36.8B | +477.9% | 7 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $26.3B | $47.4K | $16.9B | -20.5% | 10 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $25.5B | $30.3K | $14.2B | +33.1% | 6 | +0.0% | | HS 300220 - Vaccines: for human medicine | $14.5B | $1.2K | $10.1B | -16.5% | 2 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $19.8B | $140.2K | $9.1B | +7.9% | 6 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $3.4M | $8.8B | +31.1% | 5 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $13.4B | $6.2K | $8.5B | -4.2% | 3 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $5.5B | $409.8 | $7.1B | -15.3% | 2 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.4B | $106.9K | $6.6B | -7.0% | 4 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $7.6B | $24.5 | $5.8B | -33.5% | 2 | +0.0% | | HS 330300 - Perfumes and toilet waters | $8.5B | $134.8K | $5.0B | -2.5% | 3 | +0.0% | | HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $4.2B | $3.8 | $4.8B | -3.9% | 1 | +0.0% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $3.5B | $2.0 | $3.2B | -18.7% | 1 | +0.0% | | HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $5.2B | $19.1K | $2.8B | -11.7% | 2 | +0.0% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $53.0K | $2.8B | +5.0% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $10.7K | $2.2B | -2.3% | 2 | +0.0% | | HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $2.3 | $2.0B | -39.9% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.6B | $5.3M | $1.8B | +22.1% | 2 | +0.3% | | HS 281820 - Aluminium oxide: other than artificial corundum | $2.2B | $31.6 | $1.8B | +12.0% | 1 | +0.0% | | HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $196.0K | $1.4B | +14.4% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $232.8 | $1.4B | -4.3% | 1 | +0.0% | | HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $2.0B | $176.6 | $1.3B | -4.8% | 1 | +0.0% | | HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $1.8K | $1.3B | -37.4% | 1 | +0.0% | | HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.2B | $0.0 | $1.1B | -66.7% | 1 | +0.0% | | HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $14.7K | $1.1B | +40.3% | 1 | +0.1% | | HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $2.7B | $170.4 | $901.3M | -47.9% | 1 | +0.0% | | HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $7.9 | $871.2M | -38.6% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $62.6 | $803.3M | -31.7% | 1 | +0.0% | | HS 310520 - Fertilizers, mineral or chemical: containing the three fertilizing elements nitrogen, phosphorus and potassium | $589.9M | $29.2K | $797.1M | -75.5% | 1 | +0.9% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $134.7B calculated opportunity across 16 products. - Germany (DEU): $41.0B calculated opportunity across 15 products. - Switzerland, Liechtenstein (CHE): $35.1B calculated opportunity across 4 products. - Italy (ITA): $22.9B calculated opportunity across 4 products. - China (CHN): $22.6B calculated opportunity across 7 products. - Netherlands (NLD): $20.7B calculated opportunity across 6 products. - Belgium (BEL): $13.3B calculated opportunity across 4 products. - Canada (CAN): $11.6B calculated opportunity across 7 products. - United Kingdom (GBR): $11.5B calculated opportunity across 6 products. - France (FRA): $9.8B calculated opportunity across 6 products. - Slovenia (SVN): $9.7B calculated opportunity across 1 products. - Japan (JPN): $9.1B calculated opportunity across 4 products. ## Growth stars - HS 300214: +477.9% average CAGR, $36.8B calculated opportunity. - HS 300215: +256.4% average CAGR, $58.0B calculated opportunity. - HS 321590: +40.3% average CAGR, $1.1B calculated opportunity. - HS 300212: +33.1% average CAGR, $14.2B calculated opportunity. - HS 330499: +31.1% average CAGR, $8.8B calculated opportunity. - HS 293719: +24.8% average CAGR, $48.0B calculated opportunity. - HS 300290: +22.1% average CAGR, $1.8B calculated opportunity. - HS 300670: +14.4% average CAGR, $1.4B calculated opportunity. - HS 300490: +13.6% average CAGR, $117.6B calculated opportunity. - HS 281820: +12.0% average CAGR, $1.8B calculated opportunity. ## Diversification opportunities - HS 300490: 23 buyer markets, $117.6B calculated opportunity. - HS 300215: 11 buyer markets, $58.0B calculated opportunity. - HS 382499: 10 buyer markets, $16.9B calculated opportunity. - HS 300214: 7 buyer markets, $36.8B calculated opportunity. - HS 300212: 6 buyer markets, $14.2B calculated opportunity. - HS 382200: 6 buyer markets, $9.1B calculated opportunity. - HS 330499: 5 buyer markets, $8.8B calculated opportunity. - HS 293719: 4 buyer markets, $48.0B calculated opportunity. - HS 300439: 4 buyer markets, $6.6B calculated opportunity. - HS 293499: 3 buyer markets, $8.5B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.